Latest news
Regeneron Pharma Q2 Earnings: EYLEA HD Outsold EYLEA for the First Time - TIKR.comTIKR.com · Mon, 03 Aug 2026 10:24:38 GMTRegeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Strong Buy Ratings Propel Potential 9.3% Upside - DirectorsTalk InterviewsDirectorsTalk Interviews · Mon, 03 Aug 2026 09:13:30 GMTSanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs - BioPharma DiveBioPharma Dive · Fri, 31 Jul 2026 15:18:11 GMTRegeneron Pharma: Fully Repaid Sanofi Development Balance By 2Q End >REGN - MoomooMoomoo · Thu, 30 Jul 2026 16:14:55 GMTBooming Dupixent sales fuel Regeneron's biggest quarter since pandemic - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMTRegeneron Pharma: About 50 Product Candidates in Clinical Development >REGN - MoomooMoomoo · Thu, 30 Jul 2026 07:00:00 GMT